NCT06241066View on ClinicalTrials.gov

The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

359

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
OTHER

no-Intervention

no-Intervention

Trial Locations (1)

300060

Tianjin Cancer Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER

NCT06241066 - The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter